BEZ235
Encyclopedia
BEZ235 or NVP-BEZ235 is an imidazoquinoline
derivative and PI3K inhibitor being investigated as a possible cancer treatment.
It has been shown to be toxic to Waldenström's macroglobulinemia cells.
It was the first PI3K inhibitor to enter clinical trials, in 2006 (primary outcome results due in 2010).
Imidazoquinoline
Imidazoquinoline is a double cyclic organic molecule; its derivatives and compounds are often used for antiviral and antiallergic creams....
derivative and PI3K inhibitor being investigated as a possible cancer treatment.
It has been shown to be toxic to Waldenström's macroglobulinemia cells.
It was the first PI3K inhibitor to enter clinical trials, in 2006 (primary outcome results due in 2010).